Skip to main content
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. — Investor Relations & Filings

Ticker · RLAY ISIN · US75943R1023 US Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2020-07-16 Director's Dealing
Country US United States of America
Listing US RLAY

About Relay Therapeutics, Inc.

https://relaytx.com/

Relay Therapeutics, Inc. is a clinical-stage precision medicines company focused on transforming the drug discovery process. The company's approach is centered on understanding protein motion, utilizing its proprietary Dynamo® platform which integrates advanced computational and experimental methods. This platform enables the visualization of protein dynamics to design novel therapies for targets that have been historically considered intractable or 'undruggable'. Relay Therapeutics is advancing a pipeline of therapeutic candidates with an initial focus on precision oncology and genetic diseases.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-07-16 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Amendment No. 4 filed with the SEC, which is a registration statement under the Securities Act of 1933. It is related to the registration of securities for a public offering, including details about the offering, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration. This type of filing is a capital markets document used for initial public offerings or other securities offerings, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration and offering information, confirming it is not merely an announcement or a certification but a substantive filing related to capital raising.
2020-07-15 English
Regulatory Filings 2020
Regulatory Filings
2020-07-15 English
FORM S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is used for registering securities for an initial public offering (IPO). The text includes details about the offering, company overview, risk factors, use of proceeds, capitalization, underwriting, and other IPO-related disclosures. This is not a financial report like an annual or quarterly report, nor is it a call transcript, audit report, or management report. It is a capital markets filing related to the company's financing and capital raising activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement amendment, not a brief announcement or a report publication announcement.
2020-07-15 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter responding to comments from the SEC staff regarding an Amendment No. 1 to a Registration Statement on Form S-1 filed by Relay Therapeutics, Inc. It discusses revisions to the Registration Statement and provides detailed responses to SEC comments, including financial statement notes and disclosures related to convertible preferred stock. The document is not the Registration Statement itself but a correspondence letter addressing regulatory comments and amendments to the filing. This type of document is a regulatory correspondence related to a registration statement, which fits best under the category of Regulatory Filings (RNS).
2020-07-14 English
FORM S-1/A
Regulatory Filings Classification · 95% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to the initial public offering (IPO) of Relay Therapeutics, Inc. The text includes detailed information about the offering, company overview, risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, management, executive compensation, principal stockholders, and underwriting. This type of filing is a registration statement for securities offering, not a financial report, earnings release, or other types of filings listed. The closest matching category in the provided list is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories, including SEC registration statements like Form S-1/A.
2020-07-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.